Pets at Home stock holds its ground as FY2025 earnings edge higher
Published on 07/19/2026 at 17:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Pets at Home stock has been trading steadily on the London Stock Exchange as the UK pet-care group (ISIN GB00B29H4253) digests its latest full-year results, which showed modest earnings growth in FY2025 alongside continued investment in veterinary services and online capabilities.
FY2025 revenue and profit trends
According to the companys latest published annual figures for the 52 weeks to the end of March 2025, Pets at Home generated group revenue of around GBP 1.5 billion, with total sales growing in the low single-digit percentage range versus the prior financial year.
Within this total, retail operations including pet food, accessories, and in-store services remained the largest contributor, while the veterinary division continued to expand its share of group revenue compared with the previous financial year, reflecting the strategic focus on higher-margin clinical services.
Group underlying profit before tax for FY2025 increased slightly year over year, rising by a low single-digit percentage compared with FY2024, as ongoing cost inflation in areas such as labor and energy was partly offset by operational efficiencies, pricing actions, and a continued shift toward services and subscription-based offerings.
Earnings comparison and margin dynamics
On a comparative basis, the FY2025 revenue increase represented a further step up from the growth delivered in FY2024, when group revenue was also in the region of GBP 1.5 billion but at a lower base, indicating that the company has sustained positive top-line momentum over a multiyear period despite pressures on UK consumer spending.
While cost inflation constrained margin expansion, Pets at Home reported that underlying profit before tax in FY2025 remained ahead of pre-pandemic levels, highlighting how the business has structurally improved its earnings power compared with several years ago when it delivered materially lower profitability on a smaller revenue base.
The profitability comparison underscores the importance of the higher-margin veterinary segment and subscription income, as management has pointed to these areas as key levers to support earnings resilience and potential margin improvement over time, even if headline revenue growth remains in a modest single-digit range.
Dividend and cash-flow profile
In addition to earnings, the company reported that it maintained a full-year ordinary dividend for FY2025 that was broadly in line with the prior year, signaling managements confidence in the underlying cash generation of the business and its ability to fund ongoing capital expenditure and shareholder returns simultaneously.
Free cash flow for FY2025, after lease payments and capital expenditure on store refurbishments, digital systems, and veterinary practice development, remained solidly positive, supporting the funding of the ordinary dividend and selective share buybacks while keeping net debt at a level that management regards as consistent with its leverage targets.
Compared with earlier years when capital spending was lower, FY2025 saw a higher absolute investment in technology and clinical capacity, which has implications for future revenue and earnings, as these investments are intended to drive higher customer engagement, better use of data, and a broader range of services over the medium term.
Veterinary and subscription growth
A key pillar of the Pets at Home strategy is the expansion of its veterinary business, which includes companion animal veterinary practices and related services embedded in or adjacent to retail locations and stand-alone clinics, as well as digitally enabled offerings.
In FY2025, the number of active veterinary clients increased versus FY2024, and the company reported that revenue from veterinary operations grew faster than group revenue, reinforcing the strategic pivot toward this segment as a driver of higher-margin growth.
Pets at Home has also highlighted growth in subscription-based services such as health plans and repeat-delivery programs, which are designed to create more predictable, recurring revenue streams and deepen customer loyalty compared with purely transactional retail spend.
Online and omnichannel performance
Alongside its bricks-and-mortar footprint, Pets at Home continued to develop its omnichannel capabilities in FY2025, with online sales contributing a meaningfully larger share of total retail revenue than several years ago, supported by click-and-collect and home-delivery options integrated with the store network.
The company has invested in technology platforms, data analytics, and digital customer journeys, with the aim of increasing cross-sell and up-sell opportunities between retail products and veterinary services as it leverages its customer data across channels.
Management has emphasized that an integrated omnichannel model is central to its long-term strategy, as cross-channel customers typically exhibit higher spending and loyalty than those who shop only in-store or online in isolation.
Market positioning in UK pet care
Pets at Home occupies a leading position in the UK pet-care market, combining pet food and accessories retailing with veterinary services, grooming, and advice, which differentiates it from pure-play online retailers and smaller independent pet shops.
The UK pet-care market has expanded over the past decade as pet ownership increased and spending per pet rose, particularly in areas such as veterinary care, specialist nutrition, and premium accessories, trends that supported the companys revenue trajectory in FY2025.
However, the broader consumer environment has been characterized by cost-of-living pressures, which could influence discretionary categories such as non-essential accessories, even as spending on core items like food and essential veterinary care remains more resilient.
Technical picture and stock context
Pets at Home stock reflects investors assessment of these fundamentals and the balance between growth and cost pressures, with the share price in 2025 moving within a band that kept the companys market capitalization in the mid-single-digit billions of pounds on the London Stock Exchange.
From a technical perspective, the shares have in recent months traded around the middle of their 52-week range, with periods of strength following earnings updates and strategic announcements and periods of weakness when concerns about the UK consumer backdrop or cost inflation intensified.
This trading pattern suggests that the market is weighing the supportive long-term trends in pet care and the companys strategic initiatives against near-term macroeconomic uncertainty and input-cost headwinds.
Product focus on pet nutrition
One representative example of the companys commercial proposition is its range of advanced pet nutrition products, which cater to different life stages, breeds, and health conditions and are designed to complement veterinary advice available through its clinics.
Higher-value nutrition ranges, including specialist dry food, wet food, and supplements, have become an increasingly important category within the retail division, as customers seek tailored solutions and are willing to pay more for perceived health benefits for their pets.
The integration of product offerings with professional guidance in-store and through veterinary practices is a key element of the Pets at Home model, as it aims to convert visits for clinical services or check-ups into broader retail and subscription relationships.
Pets at Home stock and valuation backdrop
Pets at Home stock continues to trade in a valuation range that reflects both the defensive characteristics associated with recurring spending on pet care and the cyclical influences of the broader UK consumer economy on discretionary categories and sentiment toward mid-cap domestic equities.
Investors following the stock are paying close attention to the trajectory of revenue growth in the veterinary and subscription segments, the ability to protect or expand margins in the face of cost pressures, and the companys capital allocation between investment, dividends, and share repurchases.
Key facts on Pets at Home
- Company: Pets at Home Group plc
- ISIN: GB00B29H4253
- Ticker: LSE: PETS
- Trading venue: London Stock Exchange
- Sector / Industry: Consumer Discretionary / Specialty Retail, Pet Care and Veterinary Services
- Index membership: FTSE 250
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
